Saturday, June 7, 2025

Monthly Archives: June, 2020

New Pilot Program to Help Stop Illegal Availability of Unapproved Opioids Online

June 08, 2020: "The U.S. Food and Drug Administration and the National Telecommunications and Information Administration (NTIA) are launching a 120-day pilot to help...

FibroGen Announces First Patient Enrolled in Pamrevlumab Clinical Trial in Patients Hospitalized in Italy with Severe COVID-19

June 08, 2020, FibroGen, Inc. (NASDAQ: FGEN) today announced the initiation of an open-label, randomized, parallel-arm study investigating the efficacy and safety of pamrevlumab versus...

FDA’s ok for Chembio Zika blood test

June 08, 2020 "Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced it has received U.S. Food and Drug...

AstraZeneca Reportedly Approaches Gilead for Potential Merger

JUN 8, 2020 AstraZeneca AZN approached Gilead Sciences GILD last month for a potential merger deal, Bloomberg reported on Sunday, citing people familiar with the matter. The report mentioned...

OX2 Therapeutics receives FDA approval for a Phase I Clinical trial to treat High Grade Glioblastoma

June 08, 2020, OX2 Therapeutics, Inc, a privately held Minneapolis company, announced that ""it has received clearance from the U.S. Food and Drug Administration...

FDA Publicly Shares Antibody Test Performance Data From Kits as Part of Validation Study

June 04, 2020: "U.S. Food and Drug Administration publicly posted test performance data from four more antibody, or serology, test kits on open.fda.gov from its independent...

FDA Approves Antibiotic to Treat Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia

June 04, 2020: "U.S. Food and Drug Administration approved Recarbrio (a combination of imipenem-cilastatin and relebactam) to treat hospital-acquired bacterial pneumonia and ventilator-associated...

Coronavirus (COVID-19) Update: Daily Roundup June 4, 2020

June 04, 2020: "The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: Today, the...

The big twist on the largest clinical trial with Hydroxychloroquine

June 03, 2020: The Lancet retracted the biggest study published regarding Hydroxychloroquine use for the treatment of COVID19. "This study included all...

Data from RINVOQ&#Phase 3 Studies Presented at 2020 Annual European E-Congress of Rheumatolo

 June 04, 2020: "AbbVie, a research-based global biopharmaceutical company announced new long-term results showing that once daily upadacitinib continued to improve signs and symptoms...

Coronavirus (COVID-19) Update: Daily Roundup June 3, 2020

June 03, 2020: "The U.S. FDA announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: The FDA announced a new...

Novartis PREVENT data show Cosentyx® for relief in axial spondyloarthritis

June 4, 2020: "Novartis, a leader in rheumatology and immuno-dermatology announced the full 52-week results from the Phase III PREVENT trial, which reinforce the...
- Advertisment -

Most Read